Variant report
Variant | rs2605330 |
---|---|
Chromosome Location | chr12:74885217-74885218 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:74883702..74885504-chr12:74913172..74915992,2 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs10161125 | 0.82[ASN][1000 genomes] |
rs10785124 | 0.94[AFR][1000 genomes];0.84[ASN][1000 genomes] |
rs10785126 | 0.96[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10785127 | 0.82[ASN][1000 genomes] |
rs10879793 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11180093 | 0.83[ASN][1000 genomes] |
rs11180097 | 0.92[AFR][1000 genomes];0.82[AMR][1000 genomes] |
rs12816388 | 0.96[CEU][hapmap];0.90[CHB][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.87[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs1389492 | 0.97[AFR][1000 genomes];0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs1461048 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1461050 | 0.86[CHB][hapmap];0.95[JPT][hapmap];0.90[YRI][hapmap];1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.94[ASN][1000 genomes] |
rs1493797 | 0.95[CHB][hapmap];0.95[JPT][hapmap];0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1493805 | 0.95[CEU][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1493806 | 1.00[ASW][hapmap];0.96[CEU][hapmap];0.85[CHB][hapmap];0.95[CHD][hapmap];0.85[GIH][hapmap];0.82[LWK][hapmap];0.96[MKK][hapmap];0.91[TSI][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs2365916 | 0.84[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs2365917 | 0.84[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs2445435 | 0.85[ASN][1000 genomes] |
rs2605331 | 1.00[AFR][1000 genomes];0.86[ASN][1000 genomes] |
rs2605361 | 1.00[CEU][hapmap];0.86[AFR][1000 genomes];0.85[EUR][1000 genomes] |
rs2605374 | 0.83[ASN][1000 genomes] |
rs2605377 | 0.90[CHB][hapmap];0.90[JPT][hapmap];0.83[ASN][1000 genomes] |
rs2613882 | 0.96[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2613887 | 0.94[AFR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs2613888 | 0.93[AFR][1000 genomes];0.92[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2613891 | 0.95[AFR][1000 genomes];0.86[ASN][1000 genomes] |
rs2613895 | 0.85[CHB][hapmap] |
rs2613900 | 0.83[ASN][1000 genomes] |
rs2613903 | 0.93[ASW][hapmap];0.85[CHB][hapmap];0.93[CHD][hapmap] |
rs2641467 | 1.00[ASW][hapmap];0.96[CEU][hapmap];0.90[CHB][hapmap];0.95[CHD][hapmap];0.86[GIH][hapmap];0.95[LWK][hapmap];1.00[MKK][hapmap];0.91[TSI][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs2641468 | 0.85[CHB][hapmap] |
rs2641481 | 0.97[AFR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs2886508 | 0.82[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs2886510 | 0.81[ASN][1000 genomes] |
rs4143961 | 0.84[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs597888 | 0.85[CHB][hapmap];0.86[JPT][hapmap];0.81[ASN][1000 genomes] |
rs628576 | 0.85[CHB][hapmap];0.86[JPT][hapmap];0.81[ASN][1000 genomes] |
rs647129 | 0.83[ASN][1000 genomes] |
rs6582221 | 0.80[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs8744 | 0.86[CHD][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1039468 | chr12:74080586-75000246 | Weak transcription Enhancers Genic enhancers Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
2 | nsv1052996 | chr12:74710909-74891621 | Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
3 | nsv541540 | chr12:74710909-74891621 | Enhancers Flanking Active TSS Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
4 | nsv559413 | chr12:74754590-74924819 | Enhancers Weak transcription Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 6 gene(s) | inside rSNPs | diseases |
5 | nsv899292 | chr12:74835107-74934162 | Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Genic enhancers Enhancers Weak transcription Strong transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 5 gene(s) | inside rSNPs | diseases |
6 | nsv899293 | chr12:74835107-74995760 | Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 5 gene(s) | inside rSNPs | diseases |
7 | nsv899294 | chr12:74843754-74906884 | Active TSS Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
8 | nsv559414 | chr12:74850206-74931349 | Enhancers Flanking Active TSS Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | n/a |
9 | nsv469474 | chr12:74850683-74888100 | Flanking Active TSS Enhancers Active TSS Weak transcription | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
10 | nsv559415 | chr12:74850683-74888100 | Weak transcription Enhancers Flanking Active TSS Active TSS | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
11 | nsv899295 | chr12:74854750-74984992 | Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 5 gene(s) | inside rSNPs | diseases |
12 | nsv469475 | chr12:74857957-74922723 | Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
13 | nsv469476 | chr12:74857957-74922723 | Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
14 | nsv559416 | chr12:74857957-74922723 | Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | inside rSNPs | n/a |
15 | nsv559417 | chr12:74857957-74931349 | Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | n/a |
16 | nsv470303 | chr12:74880668-74945356 | Flanking Active TSS Weak transcription Enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 5 gene(s) | inside rSNPs | n/a |
17 | nsv899296 | chr12:74880668-74974630 | Enhancers Strong transcription Flanking Active TSS Genic enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 5 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:74880400-74885400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr12:74884400-74885600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr12:74884800-74885400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
4 | chr12:74884800-74885600 | Enhancers | Dnd41 | blood |
5 | chr12:74884800-74885800 | Enhancers | GM12878-XiMat | blood |